|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5100 CAD | 0.00% |
|
-1.92% | +12.09% |
| 03/06 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 02/06 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 2.01x | 20.69x | 43.92x | 62.39M | ||
| -.--% | -.--% | 15.78x | 1.39x | 0.61x | 9.6x | 10.31x | 13.61B | ||
| -.--% | 1.02% | 20.25x | 2.47x | 0.99x | 15.28x | 15.62x | 6.72B | ||
| 2.4% | 2.71% | 15.54x | 1.62x | 0.69x | 7.19x | 9.06x | 5.75B | ||
| 3.54% | 3.91% | 12.14x | 1.83x | 0.77x | 5.52x | 7.22x | 3.43B | ||
| 5.64% | 6.26% | 14.67x | 4.4x | 1.24x | 7.54x | 14.63x | 3.28B | ||
| 4.08% | 4.48% | 15.84x | 7.16x | 0.96x | 7.18x | 9.98x | 3.24B | ||
| 5.66% | 5.97% | 12.21x | 2.29x | 0.49x | 3.88x | 6.41x | 2.66B | ||
| 1.74% | 2.11% | 23.55x | 4.12x | 0.67x | 8.64x | 14.14x | 1.71B | ||
| 0.01% | -.--% | -89.59x | 2.94x | 0.47x | 17.47x | 105.62x | 1.55B | ||
| 5.66% | 6.37% | 11.7x | 2.35x | 0.86x | 7.03x | 13.27x | 976M | ||
| 4.51% | 5.08% | 11.24x | 0.8x | 0.26x | 2.53x | 5.22x | 886M | ||
| 1.31% | 1.91% | 27.45x | 7.41x | 0.99x | 13.54x | 21.42x | 811M | ||
| Average | 2.88% | 3.32% | 7.56x | 3.23x | 0.85x | 9.70x | 21.29x | 3.44B | |
| Weighted average by Cap. | 1.93% | 2.3% | 12.53x | 2.59x | 0.76x | 9.29x | 14.43x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















